Kalaris Therapeutics 2Q Loss/Shr 48c >KLRS

Dow Jones2026/08/11 12:04

By:Dow Jones

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

STRIVE INC : B. RILEY RAISES TARGET PRICE TO $33 FROM $26

Reuters•2026/09/22 12:05

--B. Riley Raises Price Target on Solana to $4 From $3.50, Keeps Buy Rating

MT newswire•2026/09/22 12:01

NASDAQ TRADE HALT <VOOB.O> REASON NOT AVAILABLE AT 07:55 AM

Reuters•2026/09/22 11:55

ABIVAX SA : WEDBUSH CUTS TARGET PRICE TO $118 FROM $140

Reuters•2026/09/22 11:23